261 related articles for article (PubMed ID: 21321115)
1. Engineered conformation-dependent VEGF peptide mimics are effective in inhibiting VEGF signaling pathways.
Vicari D; Foy KC; Liotta EM; Kaumaya PT
J Biol Chem; 2011 Apr; 286(15):13612-25. PubMed ID: 21321115
[TBL] [Abstract][Full Text] [Related]
2. A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis.
Farzaneh Behelgardi M; Zahri S; Mashayekhi F; Mansouri K; Asghari SM
Sci Rep; 2018 Dec; 8(1):17924. PubMed ID: 30560942
[TBL] [Abstract][Full Text] [Related]
3. Combination treatment with HER-2 and VEGF peptide mimics induces potent anti-tumor and anti-angiogenic responses in vitro and in vivo.
Foy KC; Liu Z; Phillips G; Miller M; Kaumaya PT
J Biol Chem; 2011 Apr; 286(15):13626-37. PubMed ID: 21325276
[TBL] [Abstract][Full Text] [Related]
4. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R
Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904
[TBL] [Abstract][Full Text] [Related]
5. Tissue inhibitor of metalloproteinases-3 peptides inhibit angiogenesis and choroidal neovascularization in mice.
Qi JH; Ebrahem Q; Ali M; Cutler A; Bell B; Prayson N; Sears J; Knauper V; Murphy G; Anand-Apte B
PLoS One; 2013; 8(3):e55667. PubMed ID: 23469166
[TBL] [Abstract][Full Text] [Related]
6. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
[TBL] [Abstract][Full Text] [Related]
7. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
8. Penduliflaworosin, a Diterpenoid from Croton crassifolius, Exerts Anti-Angiogenic Effect via VEGF Receptor-2 Signaling Pathway.
Liang Y; Zhang Y; Wang G; Li Y; Huang W
Molecules; 2017 Jan; 22(1):. PubMed ID: 28098802
[TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenic effect of a chemically sulfated polysaccharide from Phellinus ribis by inhibiting VEGF/VEGFR pathway.
Ding J; Jia W; Cui Y; Jin J; Zhang Y; Xu L; Liu Y
Int J Biol Macromol; 2020 Jul; 154():72-81. PubMed ID: 32171839
[TBL] [Abstract][Full Text] [Related]
10. A KDR-binding peptide (ST100,059) can block angiogenesis, melanoma tumor growth and metastasis in vitro and in vivo.
Rastelli L; Valentino ML; Minderman MC; Landin J; Malyankar UM; Lescoe MK; Kitson R; Brunson K; Souan L; Forenza S; Goldfarb RH; Rabbani SA
Int J Oncol; 2011 Aug; 39(2):401-8. PubMed ID: 21567086
[TBL] [Abstract][Full Text] [Related]
11. Potent inhibition of angiogenesis by D,L-peptides derived from vascular endothelial growth factor receptor 2.
Piossek C; Thierauch KH; Schneider-Mergener J; Volkmer-Engert R; Bachmann MF; Korff T; Augustin HG; Germeroth L
Thromb Haemost; 2003 Sep; 90(3):501-10. PubMed ID: 12958620
[TBL] [Abstract][Full Text] [Related]
12. UPARANT: a urokinase receptor-derived peptide inhibitor of VEGF-driven angiogenesis with enhanced stability and in vitro and in vivo potency.
Carriero MV; Bifulco K; Minopoli M; Lista L; Maglio O; Mele L; Di Carluccio G; De Rosa M; Pavone V
Mol Cancer Ther; 2014 May; 13(5):1092-104. PubMed ID: 24705350
[TBL] [Abstract][Full Text] [Related]
13. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
14. VEGFR2 Mimicking Peptide Inhibits the Proliferation of Human Umbilical Vein Endothelial Cells (Huvecs) by Blocking VEGF.
Ghasemali S; Barzegar A; Farajnia S; Rahmati M; Negahdari B; Etemadi A; Nazari A
Anticancer Agents Med Chem; 2023; 23(14):1678-1688. PubMed ID: 37194933
[TBL] [Abstract][Full Text] [Related]
15. A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signalling.
Lien JC; Chung CL; Huang TF; Chang TC; Chen KC; Gao GY; Hsu MJ; Huang SW
Br J Pharmacol; 2019 Oct; 176(20):4034-4049. PubMed ID: 31368127
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic activity and mechanism of kaurane diterpenoids from Wedelia chinensis.
Huang W; Liang Y; Wang J; Li G; Wang G; Li Y; Chung HY
Phytomedicine; 2016 Mar; 23(3):283-92. PubMed ID: 26969382
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a designed vascular endothelial growth factor receptor antagonist helical peptide with antiangiogenic activity in vivo.
Basile A; Del Gatto A; Diana D; Di Stasi R; Falco A; Festa M; Rosati A; Barbieri A; Franco R; Arra C; Pedone C; Fattorusso R; Turco MC; D'Andrea LD
J Med Chem; 2011 Mar; 54(5):1391-400. PubMed ID: 21280635
[TBL] [Abstract][Full Text] [Related]
18. Development of a highly-potent anti-angiogenic VEGF8-109 heterodimer by directed blocking of its VEGFR-2 binding site.
Ghavamipour F; Shahangian SS; Sajedi RH; Arab SS; Mansouri K; Aghamaali MR
FEBS J; 2014 Oct; 281(19):4479-94. PubMed ID: 25132001
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
20. Xiaotan Sanjie decoction inhibits angiogenesis in gastric cancer through Interleukin-8-linked regulation of the vascular endothelial growth factor pathway.
Shi J; Lu Y; Wei P
J Ethnopharmacol; 2016 Aug; 189():230-7. PubMed ID: 27224240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]